LUNG DISEASE INFECTIVE EXACERBATION

This adverse event was reported 27 times

These drugs are most commonly taken by patients reporting LUNG DISEASE INFECTIVE EXACERBATION:

# Drug Count
0 FLUDARABINE PHOSPHATE 16
1 RITUXIMAB 16
2 TACROLIMUS 16
3 TACROLIMUS EXTENDED-RELEASE CAPSULES 16
4 TACROLIMUS OINTMENT 0.1% 16
5 THIOTEPA 16
6 TREOSULFAN 16
7 INFLIXIMAB 15
8 PREDNISONE 15
9 RUXOLITINIB 15
See all common drugs associated with LUNG DISEASE INFECTIVE EXACERBATION

LUNG DISEASE INFECTIVE EXACERBATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CIDOFOVIR ANHYDROUS 10 0.0069
1 DEFEROXAMINE MESYLATE 14 0.0064
2 TREOSULFAN 16 0.0058
3 MARIBAVIR 10 0.0041
4 LETERMOVIR 10 0.0031
5 THIOTEPA 16 0.0016
6 ANTI-THYMOCYTE GLOBULIN (RABBIT) 12 0.0015
7 FOSTAMATINIB 10 0.0013
8 GANCICLOVIR SODIUM 10 0.0009
9 ANAKINRA 10 0.0006
See all drugs enriched for association with LUNG DISEASE INFECTIVE EXACERBATION